These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3421805)

  • 1. How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate.
    Georgotas A; McCue RE; Cooper TB; Nagachandran N; Chang I
    Arch Gen Psychiatry; 1988 Oct; 45(10):929-32. PubMed ID: 3421805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients.
    Georgotas A; McCue RE; Cooper TB
    Arch Gen Psychiatry; 1989 Sep; 46(9):783-6. PubMed ID: 2673129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
    Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
    Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse of depressed patients after effective continuation therapy.
    Georgotas A; McCue RE
    J Affect Disord; 1989; 17(2):159-64. PubMed ID: 2527891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
    Georgotas A; McCue RE; Friedman E; Cooper T
    Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of depressive symptoms to nortriptyline, phenelzine and placebo.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    Br J Psychiatry; 1987 Jul; 151():102-6. PubMed ID: 3676606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of phenelzine in continuation therapy.
    Davidson J; Raft D
    Neuropsychobiology; 1984; 11(3):191-4. PubMed ID: 6433222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report.
    Reynolds CF; Frank E; Perel JM; Imber SD; Cornes C; Morycz RK; Mazumdar S; Miller MD; Pollock BG; Rifai AH
    Am J Psychiatry; 1992 Dec; 149(12):1687-92. PubMed ID: 1443245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The usefulness of DST in predicting response to antidepressants: a placebo-controlled study.
    Georgotas A; Stokes P; McCue RE; Dubow A; Welkowitz J; Friedman E; Fanelli C; Chang I; Cooper TB
    J Affect Disord; 1986; 11(1):21-8. PubMed ID: 2944924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenelzine for chronic depression: a study of continuation treatment.
    Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
    J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 10-Hydroxynortriptyline and treatment effects in elderly depressed patients.
    McCue RE; Georgotas A; Suckow RF; Cooper TB
    J Neuropsychiatry Clin Neurosci; 1989; 1(2):176-80. PubMed ID: 2521060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.
    Georgotas A; McCue RE; Hapworth W; Friedman E; Kim OM; Welkowitz J; Chang I; Cooper TB
    Biol Psychiatry; 1986 Oct; 21(12):1155-66. PubMed ID: 3756264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrocardiographic effects of nortriptyline, phenelzine, and placebo under optimal treatment conditions.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    Am J Psychiatry; 1987 Jun; 144(6):798-801. PubMed ID: 3592003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant specificity in atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison WM; Markowitz JS; Rabkin JG; Tricamo E; Goetz DM; Klein DF
    Arch Gen Psychiatry; 1988 Feb; 45(2):129-37. PubMed ID: 3276282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenelzine vs placebo in 50 patients with bulimia.
    Walsh BT; Gladis M; Roose SP; Stewart JW; Stetner F; Glassman AH
    Arch Gen Psychiatry; 1988 May; 45(5):471-5. PubMed ID: 3282482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to phenelzine among depressed patients with features of hysteroid dysphoria.
    Kayser A; Robinson DS; Nies A; Howard D
    Am J Psychiatry; 1985 Apr; 142(4):486-8. PubMed ID: 3883817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors of response to antidepressants in elderly patients.
    Georgotas A; McCue RE; Cooper T; Chang I; Mir P; Welkowitz J
    Biol Psychiatry; 1987 Jun; 22(6):733-40. PubMed ID: 3297176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAO inhibition and clinical response in depressed patients treated with phenelzine.
    Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
    J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.